Inventor profile of:

Smita Bhat

City:

Irvine, California

Country:

United States

Published Applications:

12

Last publication date:

2013-06-13

Top Assignees for applications by Smita Bhat

The entities that hold a legal rights for patent applications filed by inventor Bhat Smita:

Recent patent applications by Bhat Smita

Smita Bhat from Irvine, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2013-06-13
US20130150331A1
Chemistry; metallurgy

Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators

#2 | 2012-08-23
US20120214838A1
Chemistry; metallurgy

Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds

#3 | 2011-09-29
US20110237797A1
Chemistry; metallurgy

Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds

#4 | 2011-03-31
US20110077274A1
Chemistry; metallurgy

Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors

#5 | 2009-08-06
US20090197898A1
Human necessities

Selective subtype alpha 2 adrenergic agents and methods for use thereof

#6 | 2008-04-24
US20080097119A1
Chemistry; metallurgy

Disubstituted chalcone oximes having RARγ retinoid receptor antagonist activity

#7 | 2008-01-03
US20080004455A1
Chemistry; metallurgy

Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same

#8 | 2005-08-25
US20050187298A1
Human necessities

Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B

#9 | 2005-08-11
US20050176689A1
Chemistry; metallurgy

Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same

#10 | 2005-07-28
US20050165095A1
Chemistry; metallurgy

Disubstituted chalcone oximes having RARγ retinoid receptor antagonist activity

#11 | 2005-07-07
US20050148590A1
Chemistry; metallurgy

Disubstituted chalcone oximes as selective agonists of RAR retinoid receptors

#12 | 2005-01-06
US20050004213A1
Chemistry; metallurgy

5-[phenyl-tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl and heteroaryl-cyclopropyl]-pentadienoic acid derivatives having serum glucose reducing activity

InventorID:

287709 ⎘